Vaccine Therapy With or Without Cyclophosphamide in Treating Patients With Recurrent or Refractory Multiple Myeloma

This study is currently recruiting participants.
Information provided by National Cancer Institute (NCI)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:

1		Additional conditions recognized in this trial
			Multiple Myeloma
			Neoplasms
			Neoplasms, Plasma Cell
2		More general conditions related to this trial
			Blood Protein Disorders
			Cardiovascular Diseases
			Hematologic Diseases
			Hemorrhagic Disorders
			Hemostatic Disorders
			Immune System Diseases
			Immunoproliferative Disorders
			Lymphoproliferative Disorders
			Neoplasms by Histologic Type
			Paraproteinemias
			Vascular Diseases
3		Interventions listed in this trial
			cyclophosphamide
			biopsy
			flow cytometry
			immunologic technique
			laboratory biomarker analysis
4		More general drug interventions related to this trial
			Alkylating Agents
			Antineoplastic Agents
			Antineoplastic Agents, Alkylating
			Antirheumatic Agents
			Immunologic Factors
			Immunosuppressive Agents
			Molecular Mechanisms of Pharmacological Action
			Myeloablative Agonists
			Pharmacologic Actions
			Physiological Effects of Drugs
			Therapeutic Uses
5		Sponsors listed in this trial
			Mayo Clinic
			National Cancer Institute (NCI)